PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,353,000 | -48.1% | 344,917 | -45.2% | 0.20% | -47.5% |
| Q4 2020 | $6,460,000 | +34.5% | 629,650 | +32.3% | 0.38% | +8.1% |
| Q3 2020 | $4,803,000 | -61.5% | 475,982 | -60.3% | 0.36% | -54.8% |
| Q2 2020 | $12,491,000 | +132.0% | 1,197,630 | +87.7% | 0.79% | +58.0% |
| Q1 2020 | $5,385,000 | +48.0% | 638,026 | +580.2% | 0.50% | +41.9% |
| Q1 2019 | $3,638,000 | -6.2% | 93,800 | -50.8% | 0.35% | -27.3% |
| Q4 2018 | $3,879,000 | -74.9% | 190,627 | -43.4% | 0.48% | -64.9% |
| Q3 2018 | $15,444,000 | +282.1% | 336,835 | +393.0% | 1.38% | +433.7% |
| Q2 2018 | $4,042,000 | – | 68,320 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |